▶ 調査レポート

新型コロナウイルス感染用症経口ワクチンの世界市場2023:錠剤タイプ、吸入タイプ

• 英文タイトル:Global Oral COVID-19 Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Oral COVID-19 Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029「新型コロナウイルス感染用症経口ワクチンの世界市場2023:錠剤タイプ、吸入タイプ」(市場規模、市場予測)調査レポートです。• レポートコード:MRC308GR11493
• 出版社/出版日:GlobalInfoResearch / 2023年8月14日
• レポート形態:英文、PDF、90ページ
• 納品方法:Eメール(2-3営業日)
• 産業分類:医薬品&ヘルスケア
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Corporate User¥783,000 (USD5,220)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要

GlobalInfoResearchの最新の調査によると、世界の新型コロナウイルス感染用症経口ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。

このレポートは、世界の新型コロナウイルス感染用症経口ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 新型コロナウイルス感染用症経口ワクチンの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため

新型コロナウイルス感染用症経口ワクチン市場は種類と用途によって区分されます。2018年~2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメント
・錠剤タイプ、吸入タイプ

用途別セグメント
・成人、子供、高齢者

主要な市場プレーヤー
・Pfizer、CanSino Biologics、Kindred Biosciences, Inc.、Zhejiang Huahai Pharmaceutical Co.,ltd.、Shandong Xinhua Pharmaceutical、Kintor Pharmaceutical、Henan Genuine Biotech Co., Ltd.

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、新型コロナウイルス感染用症経口ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な新型コロナウイルス感染用症経口ワクチンメーカーの企業概要、2019年~2022年までの新型コロナウイルス感染用症経口ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な新型コロナウイルス感染用症経口ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別新型コロナウイルス感染用症経口ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの新型コロナウイルス感染用症経口ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での新型コロナウイルス感染用症経口ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および新型コロナウイルス感染用症経口ワクチンの産業チェーンを掲載しています。
・第14、15章では、新型コロナウイルス感染用症経口ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
– 新型コロナウイルス感染用症経口ワクチンの概要
– 種類別分析(2018年vs2022年vs2029年):錠剤タイプ、吸入タイプ
– 用途別分析(2018年vs2022年vs2029年):成人、子供、高齢者
– 世界の新型コロナウイルス感染用症経口ワクチン市場規模・予測
– 世界の新型コロナウイルス感染用症経口ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Pfizer、CanSino Biologics、Kindred Biosciences, Inc.、Zhejiang Huahai Pharmaceutical Co.,ltd.、Shandong Xinhua Pharmaceutical、Kintor Pharmaceutical、Henan Genuine Biotech Co., Ltd.
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年:錠剤タイプ、吸入タイプ
・用途別分析2018年-2029年:成人、子供、高齢者
・新型コロナウイルス感染用症経口ワクチンの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・新型コロナウイルス感染用症経口ワクチンのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・新型コロナウイルス感染用症経口ワクチンのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・新型コロナウイルス感染用症経口ワクチンの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・新型コロナウイルス感染用症経口ワクチンの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Oral COVID-19 Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral COVID-19 Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablet Type
1.3.3 Inhalable Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral COVID-19 Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.4.4 Elderly
1.5 Global Oral COVID-19 Vaccine Market Size & Forecast
1.5.1 Global Oral COVID-19 Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral COVID-19 Vaccine Sales Quantity (2018-2029)
1.5.3 Global Oral COVID-19 Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Oral COVID-19 Vaccine Product and Services
2.1.4 Pfizer Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 CanSino Biologics
2.2.1 CanSino Biologics Details
2.2.2 CanSino Biologics Major Business
2.2.3 CanSino Biologics Oral COVID-19 Vaccine Product and Services
2.2.4 CanSino Biologics Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CanSino Biologics Recent Developments/Updates
2.3 Kindred Biosciences, Inc.
2.3.1 Kindred Biosciences, Inc. Details
2.3.2 Kindred Biosciences, Inc. Major Business
2.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product and Services
2.3.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Kindred Biosciences, Inc. Recent Developments/Updates
2.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
2.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Details
2.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Major Business
2.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product and Services
2.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments/Updates
2.5 Shandong Xinhua Pharmaceutical
2.5.1 Shandong Xinhua Pharmaceutical Details
2.5.2 Shandong Xinhua Pharmaceutical Major Business
2.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product and Services
2.5.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
2.6 Kintor Pharmaceutical
2.6.1 Kintor Pharmaceutical Details
2.6.2 Kintor Pharmaceutical Major Business
2.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Product and Services
2.6.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kintor Pharmaceutical Recent Developments/Updates
2.7 Henan Genuine Biotech Co., Ltd.
2.7.1 Henan Genuine Biotech Co., Ltd. Details
2.7.2 Henan Genuine Biotech Co., Ltd. Major Business
2.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product and Services
2.7.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Henan Genuine Biotech Co., Ltd. Recent Developments/Updates
3 Competitive Environment: Oral COVID-19 Vaccine by Manufacturer
3.1 Global Oral COVID-19 Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral COVID-19 Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Oral COVID-19 Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral COVID-19 Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral COVID-19 Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Oral COVID-19 Vaccine Manufacturer Market Share in 2022
3.5 Oral COVID-19 Vaccine Market: Overall Company Footprint Analysis
3.5.1 Oral COVID-19 Vaccine Market: Region Footprint
3.5.2 Oral COVID-19 Vaccine Market: Company Product Type Footprint
3.5.3 Oral COVID-19 Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Oral COVID-19 Vaccine Market Size by Region
4.1.1 Global Oral COVID-19 Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Oral COVID-19 Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Oral COVID-19 Vaccine Average Price by Region (2018-2029)
4.2 North America Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.3 Europe Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.5 South America Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Oral COVID-19 Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Oral COVID-19 Vaccine Consumption Value by Type (2018-2029)
5.3 Global Oral COVID-19 Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Oral COVID-19 Vaccine Consumption Value by Application (2018-2029)
6.3 Global Oral COVID-19 Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Oral COVID-19 Vaccine Market Size by Country
7.3.1 North America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Oral COVID-19 Vaccine Market Size by Country
8.3.1 Europe Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral COVID-19 Vaccine Market Size by Region
9.3.1 Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral COVID-19 Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Oral COVID-19 Vaccine Market Size by Country
10.3.1 South America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral COVID-19 Vaccine Market Size by Country
11.3.1 Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Oral COVID-19 Vaccine Market Drivers
12.2 Oral COVID-19 Vaccine Market Restraints
12.3 Oral COVID-19 Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Oral COVID-19 Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral COVID-19 Vaccine
13.3 Oral COVID-19 Vaccine Production Process
13.4 Oral COVID-19 Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral COVID-19 Vaccine Typical Distributors
14.3 Oral COVID-19 Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Oral COVID-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral COVID-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Oral COVID-19 Vaccine Product and Services
Table 6. Pfizer Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. CanSino Biologics Basic Information, Manufacturing Base and Competitors
Table 9. CanSino Biologics Major Business
Table 10. CanSino Biologics Oral COVID-19 Vaccine Product and Services
Table 11. CanSino Biologics Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CanSino Biologics Recent Developments/Updates
Table 13. Kindred Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Kindred Biosciences, Inc. Major Business
Table 15. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product and Services
Table 16. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Kindred Biosciences, Inc. Recent Developments/Updates
Table 18. Zhejiang Huahai Pharmaceutical Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Zhejiang Huahai Pharmaceutical Co.,ltd. Major Business
Table 20. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product and Services
Table 21. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments/Updates
Table 23. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Shandong Xinhua Pharmaceutical Major Business
Table 25. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product and Services
Table 26. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shandong Xinhua Pharmaceutical Recent Developments/Updates
Table 28. Kintor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Kintor Pharmaceutical Major Business
Table 30. Kintor Pharmaceutical Oral COVID-19 Vaccine Product and Services
Table 31. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kintor Pharmaceutical Recent Developments/Updates
Table 33. Henan Genuine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Henan Genuine Biotech Co., Ltd. Major Business
Table 35. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product and Services
Table 36. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Henan Genuine Biotech Co., Ltd. Recent Developments/Updates
Table 38. Global Oral COVID-19 Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Oral COVID-19 Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Oral COVID-19 Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Oral COVID-19 Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Oral COVID-19 Vaccine Production Site of Key Manufacturer
Table 43. Oral COVID-19 Vaccine Market: Company Product Type Footprint
Table 44. Oral COVID-19 Vaccine Market: Company Product Application Footprint
Table 45. Oral COVID-19 Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Oral COVID-19 Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Oral COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Oral COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Oral COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Oral COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Oral COVID-19 Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Oral COVID-19 Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Oral COVID-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Oral COVID-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Oral COVID-19 Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Oral COVID-19 Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Oral COVID-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Oral COVID-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Oral COVID-19 Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Oral COVID-19 Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Oral COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Oral COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Oral COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Oral COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Oral COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Oral COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Oral COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Oral COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Oral COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Oral COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Oral COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Oral COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Oral COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Oral COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Oral COVID-19 Vaccine Raw Material
Table 106. Key Manufacturers of Oral COVID-19 Vaccine Raw Materials
Table 107. Oral COVID-19 Vaccine Typical Distributors
Table 108. Oral COVID-19 Vaccine Typical Customers
List of Figures
Figure 1. Oral COVID-19 Vaccine Picture
Figure 2. Global Oral COVID-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral COVID-19 Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Tablet Type Examples
Figure 5. Inhalable Type Examples
Figure 6. Global Oral COVID-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oral COVID-19 Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Adults Examples
Figure 9. Children Examples
Figure 10. Elderly Examples
Figure 11. Global Oral COVID-19 Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Oral COVID-19 Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Oral COVID-19 Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Oral COVID-19 Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Oral COVID-19 Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Oral COVID-19 Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Oral COVID-19 Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Oral COVID-19 Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Oral COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Oral COVID-19 Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Oral COVID-19 Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Oral COVID-19 Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Oral COVID-19 Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Oral COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Oral COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Oral COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Oral COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Oral COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Oral COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Oral COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Oral COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Oral COVID-19 Vaccine Market Drivers
Figure 74. Oral COVID-19 Vaccine Market Restraints
Figure 75. Oral COVID-19 Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Oral COVID-19 Vaccine
Figure 79. Oral COVID-19 Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source